Screener
EBIT at other companies
Other financials
Where this comes from
Calculated from United Therapeutics’s reported figures.
The source filing: United Therapeutics’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 6:31 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001082554-26-000027
FAQ
- What is United Therapeutics's EBIT?
- United Therapeutics (UTHR) reported EBIT of $330.8M in Q2 2026.
- How has United Therapeutics's EBIT changed year-over-year?
- United Therapeutics's EBIT decreased by 9.2% year-over-year, from $364.5M to $330.8M.
- What is the long-term trend for United Therapeutics's EBIT?
- Over 4 years (2021 to 2025), United Therapeutics's EBIT has grown at a 28.0% compound annual growth rate (CAGR), from $555.9M to $1.49B.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.
Ask your AI about United Therapeutics's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude